DCF — ADVENTHEALTH MURRAY
Enterprise Value: $-4.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-4.9M
Enterprise Value
$-2.6M
PV of Cash Flows
$-2.3M
PV of Terminal Value
$-3.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $40.5M | $0.5M | 1.0% | $-1.2M | $-1.1M |
| Year 2 | $41.7M | $0.9M | 2.0% | $-0.8M | $-0.7M |
| Year 3 | $42.9M | $1.4M | 3.0% | $-0.5M | $-0.4M |
| Year 4 | $44.2M | $1.7M | 4.0% | $-0.4M | $-0.2M |
| Year 5 | $45.5M | $1.8M | 4.0% | $-0.3M | $-0.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-4.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$39.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.007551894679841224
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5